Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Eupraxia Pharmaceuticals Inc. (EPRX) had Return on Investments of -23.66% for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.51M |
|
-- |
|
-- |
|
$7.48M |
|
$-7.48M |
|
$-0.05M |
|
$-7.53M |
|
$-7.54M |
|
$-7.53M |
|
$-7.53M |
|
$-7.53M |
|
$-7.54M |
|
$-7.48M |
|
$-7.43M |
|
33.93M |
|
33.93M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$34.44M |
|
$0.36M |
|
$0.51M |
|
$34.94M |
|
$3.10M |
|
-- |
|
-- |
|
$3.10M |
|
$0.13M |
|
$31.84M |
|
$31.84M |
|
35.64M |
|
| Cash Flow Statement Financials | |
$-29.99M |
|
$-0.08M |
|
$45.78M |
|
$19.34M |
|
$33.10M |
|
$13.76M |
|
$3.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.10 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5631.70% |
|
-23.66% |
|
-21.56% |
|
|
Return on Investments |
-23.66% |
$0.89 |
|
$-0.89 |
|
$-0.88 |
|